• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4598436)   Today's Articles (1227)   Subscriber (49356)
Number Citation Analysis
76
&NA;. Finasteride with doxazosin to reduce BPH progression. Nurse Pract 2005;30:70. [PMID: 15753830 DOI: 10.1097/00006205-200503000-00022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
77
Steers WD, Kirby RS. Clinical ease of using doxazosin in BPH patients with and without hypertension. Prostate Cancer Prostatic Dis 2005;8:152-7. [PMID: 15711605 DOI: 10.1038/sj.pcan.4500787] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
78
Kirby RS, O'Leary MP, Carson C. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction. BJU Int 2005;95:103-9; discussion 109. [PMID: 15638905 DOI: 10.1111/j.1464-410x.2004.05252.x] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
79
Lee JY, Kim HW, Lee SJ, Koh JS, Suh HJ, Chancellor MB. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004;94:817-20. [PMID: 15476515 DOI: 10.1111/j.1464-410x.2004.05039.x] [Citation(s) in RCA: 207] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
80
Hausmann R, Thalmann G, Reich O, Steif CG. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination]. Aktuelle Urol 2004;35:339-42. [PMID: 15383991 DOI: 10.1055/s-2004-834352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
81
Kario K, Pickering TG, Hoshide S, Eguchi K, Ishikawa J, Morinari M, Hoshide Y, Shimada K. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004;17:668-75. [PMID: 15288883 DOI: 10.1016/j.amjhyper.2004.04.001] [Citation(s) in RCA: 97] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2003] [Revised: 02/21/2004] [Accepted: 04/06/2004] [Indexed: 10/26/2022]  Open
82
Fujimoto S, Mizuno R, Saito Y, Nakamura S. Clinical application of wave intensity for the treatment of essential hypertension. Heart Vessels 2004;19:19-22. [PMID: 14685750 DOI: 10.1007/s00380-003-0725-9] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2001] [Accepted: 06/27/2003] [Indexed: 11/24/2022]
83
Fitzpatrick JM, Kirby RS. Two-drug therapy is best for symptomatic prostate enlargement: could a combination of doxazosin and finasteride change clinical practice? BJU Int 2004;93:914-5. [PMID: 15142134 DOI: 10.1111/j.1464-410x.2004.04799.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
84
de Reijke TM, Klarskov P. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement. BJU Int 2004;93:757-62. [PMID: 15049986 DOI: 10.1111/j.1464-410x.2003.04720.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
85
Lee SC, Ellis RJ. Male Breast Cancer During Finasteride Therapy. J Natl Cancer Inst 2004;96:338-9. [PMID: 14970289 DOI: 10.1093/jnci/djh062] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
86
Kirby RS, Quinn S, Mallen S, Jensen D. Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis. Int J Clin Pract 2004;58:6-10. [PMID: 14994963 DOI: 10.1111/j.1368-5031.2004.0031.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]  Open
87
Mazo EB, Shashin MN. [Use of alpha-adrenoblockers in therapy of benign prostatic hyperplasia in patients with arterial hypertension]. TERAPEVT ARKH 2004;76:72-5. [PMID: 15575482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
88
Slavov C, Dimitrov R. [LUTS in women and possible therapeutic effects of alfa1-adrenoblockers]. Khirurgiia (Mosk) 2004;60:35-8. [PMID: 16042062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
89
Lorente Garín JA, Cañis Sánchez D, Arango Toro O, Bielsa Gali O, Cortadellas Angel R, Gelabert Mas A. Doxazosina en formulación de liberación retardada en la retención aguda de orina por hiperplasia benigna de próstata. acción del incremento de dosis sobre el efecto rescate. Actas Urol Esp 2004;28:32-7. [PMID: 15046478 DOI: 10.1016/s0210-4806(04)73032-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
90
Sauerbrey-Wullkopf N, Leverkus F. [Treatment of hypertension in a clinical trial. Depot alpha 1 blocker simplifies dosing]. MMW Fortschr Med 2003;145:54. [PMID: 14725035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]
91
[Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow]. MMW Fortschr Med 2003;145:62. [PMID: 14725041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]
92
Düsing R. [The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure]. MMW Fortschr Med 2003;145 Suppl 1:6. [PMID: 12958795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
93
Wilson TA, Foxall TL, Nicolosi RJ. Doxazosin, an alpha-1 antagonist, prevents further progression of the advanced atherosclerotic lesion in hypercholesterolemic hamsters. Metabolism 2003;52:1240-5. [PMID: 14564673 DOI: 10.1016/s0026-0495(03)00285-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
94
[Benign prostatic syndrome. 3-step plan for the treatment]. MMW Fortschr Med 2003;145:52. [PMID: 14649077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
95
[5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked]. MMW Fortschr Med 2003;145:58-9. [PMID: 14587193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
96
Erdoğru T, Ciftcioglu MA, Emreoglu I, Usta MF, Koksal T, Ozbilim G, Gulkesen KH, Baykara M. Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia. Urol Int 2003;69:287-92. [PMID: 12444285 DOI: 10.1159/000066120] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
97
Black HR. Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension. J Cardiovasc Pharmacol 2003;41:866-9. [PMID: 12775963 DOI: 10.1097/00005344-200306000-00006] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
98
Lemmer B, Nold G. Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension. Blood Press Monit 2003;8:119-25. [PMID: 12900589 DOI: 10.1097/00126097-200306000-00005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
99
Jiménez-García R, Anegón M, Esteban J, Carrasco P, Apaolaza I, Gil A. Safety and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therapeutic system (GITS) formulation in elderly hypertensive patients. Int J Clin Pract 2003;57:267-72. [PMID: 12800456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]  Open
100
Lund-Johansen P, Kirby RS. Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies. Blood Press 2003;1:5-13. [PMID: 12800982 DOI: 10.1080/08038020310000078] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
PrevPage 4 of 7 1234567Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA